• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产前非镰状血红蛋白病筛查中的红细胞参数

Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening.

作者信息

Bencaiova Gabriela, Dapoto Kristina, Zimmermann Roland, Krafft Alexander

机构信息

Department of Obstetrics and Gynecology, Institute of Obstetric Research, University Hospital Zurich, Zurich, Switzerland.

出版信息

Int J Womens Health. 2015 Apr 8;7:379-84. doi: 10.2147/IJWH.S73362. eCollection 2015.

DOI:10.2147/IJWH.S73362
PMID:25914560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4399595/
Abstract

OBJECTIVE

To find a hematological parameter and the cut-off level for identification of nonsickling hemoglobinopathies in pregnant women.

MATERIALS AND METHODS

Venous blood samples of 849 women with singleton pregnancies were collected at the first visit. All women who met inclusion criteria were examined for nonsickling hemoglobinopathy. On the basis of the sensitivity and the specificity of different cut-off levels for hematological parameters, we calculated the optimal clinically practicable parameter for screening of nonsickling hemoglobinopathies in pregnant women.

RESULTS

On the basis of the sensitivity and the specificity, the best screening parameters for the identification of nonsickling hemoglobinopathies among nonanemic pregnant women are mean corpuscular volume (MCV) with cut-off ≤80 fL (Youden's index 91.2%), mean corpuscular hemoglobin (MCH) <27.5 pg (Youden's index 90.7%), and microcytosis (MRC) ≥3% (Youden's index 90.2%). An analysis using receiver operating characteristic curves and the calculated Youden's index showed that MCV ≤76 fL, MCH ≤24 pg, or MRC ≥10% are the best red blood cell indices for the screening of nonsickling hemoglobinopathy among anemic women with iron deficiency.

CONCLUSION

Our results suggest targeted screening for nonsickling hemoglobinopathies in nonanemic pregnant women with MCV ≤80 fL, MCH ≤27.5 pg, or MRC ≥3% and in anemic women with MCV ≤76 fL, MCH ≤24 pg, or MRC ≥10%.

摘要

目的

寻找一种血液学参数及其临界值,用于识别孕妇中的非镰状血红蛋白病。

材料与方法

在首次就诊时收集849名单胎妊娠妇女的静脉血样本。对所有符合纳入标准的妇女进行非镰状血红蛋白病检查。根据血液学参数不同临界值的敏感性和特异性,计算出用于筛查孕妇非镰状血红蛋白病的最佳临床可行参数。

结果

基于敏感性和特异性,在非贫血孕妇中识别非镰状血红蛋白病的最佳筛查参数为平均红细胞体积(MCV)≤80 fL(约登指数91.2%)、平均红细胞血红蛋白(MCH)<27.5 pg(约登指数90.7%)和小红细胞症(MRC)≥3%(约登指数90.2%)。使用受试者工作特征曲线和计算出的约登指数进行分析表明,MCV≤76 fL、MCH≤24 pg或MRC≥10%是筛查缺铁性贫血妇女中非镰状血红蛋白病的最佳红细胞指标。

结论

我们的结果表明,对于MCV≤80 fL、MCH≤27.5 pg或MRC≥3%的非贫血孕妇以及MCV≤76 fL、MCH≤24 pg或MRC≥10%的贫血孕妇,应针对性地筛查非镰状血红蛋白病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/919c/4399595/4384ed142aa5/ijwh-7-379Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/919c/4399595/26a05eed892d/ijwh-7-379Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/919c/4399595/4384ed142aa5/ijwh-7-379Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/919c/4399595/26a05eed892d/ijwh-7-379Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/919c/4399595/4384ed142aa5/ijwh-7-379Fig2.jpg

相似文献

1
Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening.产前非镰状血红蛋白病筛查中的红细胞参数
Int J Womens Health. 2015 Apr 8;7:379-84. doi: 10.2147/IJWH.S73362. eCollection 2015.
2
Screening for beta-thalassaemia trait in anaemic pregnant women.对贫血孕妇进行β地中海贫血特征筛查。
Gynecol Obstet Invest. 2006;62(1):20-7. doi: 10.1159/000091813. Epub 2006 Mar 1.
3
Can RBC Indices be Used as Screening Test for Beta-Thalassemia in Indian Antenatal Women?红细胞指数能否作为印度产前女性β地中海贫血的筛查测试?
J Obstet Gynaecol India. 2019 Dec;69(6):495-500. doi: 10.1007/s13224-019-01220-8. Epub 2019 Mar 28.
4
Thalassemia and Hemoglobinopathy Screening in Women Attending Antenatal Clinic at a Tertiary Care Center in Uttarakhand, India: A Re-look at the Laboratory Parameters Mandating High-Performance Liquid Chromatography Workup.印度北阿坎德邦一家三级医疗中心产前检查门诊女性的地中海贫血和血红蛋白病筛查:重新审视需要高效液相色谱分析的实验室参数。
Cureus. 2023 Jun 19;15(6):e40667. doi: 10.7759/cureus.40667. eCollection 2023 Jun.
5
Screening for hemochromatosis in routine medical care: an evaluation of mean corpuscular volume and mean corpuscular hemoglobin.常规医疗保健中血色病的筛查:平均红细胞体积和平均红细胞血红蛋白的评估
Genet Test. 2000;4(2):103-10. doi: 10.1089/10906570050114786.
6
Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India: Experience of 18,166 cases.印度东部地中海贫血及其他血红蛋白病的人群筛查与预防策略:18166例病例的经验
Hemoglobin. 2015;39(6):384-8. doi: 10.3109/03630269.2015.1068799. Epub 2015 Oct 1.
7
Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome.红细胞指数(MCV、MCH 和 MCHC)与贫血和非贫血急性冠状动脉综合征患者主要不良心血管事件的关系。
Dis Markers. 2022 Nov 3;2022:2193343. doi: 10.1155/2022/2193343. eCollection 2022.
8
Evaluation of Thalassaemia Screening Tests in the Antenatal and Non-Antenatal Populations in Singapore.新加坡产前和非产前人群中地中海贫血筛查试验的评估。
Ann Acad Med Singap. 2019 Jan;48(1):5-15.
9
[Diagnostic Cut-Off Value of RDW for Screening Thalassemia and the Combined Determination of MCV, MCH, HBA and RDW].[红细胞分布宽度(RDW)用于筛查地中海贫血的诊断临界值及平均红细胞体积(MCV)、平均红细胞血红蛋白含量(MCH)、血红蛋白A(HBA)与RDW的联合检测]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Jun;29(3):847-852. doi: 10.19746/j.cnki.issn.1009-2137.2021.03.030.
10
Accuracy of Various Iron Parameters in the Prediction of Iron Deficiency Anemia among Healthy Women of Child Bearing Age, Saudi Arabia.沙特阿拉伯育龄健康女性中各种铁参数对缺铁性贫血预测的准确性
Iran Red Crescent Med J. 2012 Jul;14(7):397-401. Epub 2012 Jul 30.

本文引用的文献

1
Neonatal/newborn haemoglobinopathy screening in Europe and Africa.欧洲和非洲的新生儿血红蛋白病筛查
J Clin Pathol. 2009 Jan;62(1):53-6. doi: 10.1136/jcp.2008.060624.
2
Neonatal haemoglobinopathy screening in Belgium.比利时的新生儿血红蛋白病筛查。
J Clin Pathol. 2009 Jan;62(1):49-52. doi: 10.1136/jcp.2008.060517.
3
Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma.通过数字大小选择和母体血浆中DNA的相对突变剂量对单基因疾病进行无创产前诊断。
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19920-5. doi: 10.1073/pnas.0810373105. Epub 2008 Dec 5.
4
Screening and genetic diagnosis of haemoglobinopathies.血红蛋白病的筛查与基因诊断
Scand J Clin Lab Invest. 2007;67(1):71-86. doi: 10.1080/00365510601046466.
5
Screening for beta-thalassaemia trait in anaemic pregnant women.对贫血孕妇进行β地中海贫血特征筛查。
Gynecol Obstet Invest. 2006;62(1):20-7. doi: 10.1159/000091813. Epub 2006 Mar 1.
6
Haemoglobinopathy in pregnancy: diagnosis and treatment.
Curr Med Chem. 2004 Nov;11(21):2903-9. doi: 10.2174/0929867043364180.
7
Iron status in anemic pregnant women.贫血孕妇的铁状态
J Obstet Gynaecol Res. 2003 Jun;29(3):160-3. doi: 10.1046/j.1341-8076.2003.00094.x.
8
The simultaneous presence of alpha- and beta-thalassaemia alleles: a pitfall of thalassaemia screening.α-地中海贫血和β-地中海贫血等位基因的同时存在:地中海贫血筛查的一个陷阱。
Community Genet. 2003;6(1):14-21. doi: 10.1159/000069539.
9
Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia.地中海贫血特征与缺铁性贫血鉴别中最可靠的指标。
Pediatr Int. 2002 Dec;44(6):612-6. doi: 10.1046/j.1442-200x.2002.01636.x.
10
Outcomes of universal antenatal screening for haemoglobinopathies.血红蛋白病普遍产前筛查的结果。
J Med Screen. 1999;6(1):3-10. doi: 10.1136/jms.6.1.3.